SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Profit After Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Profit After Tax | ₹25 Cr | ₹20 Cr | ₹20 Cr | ₹11 Cr | ₹10 Cr |
What is the latest Profit After Tax of SYNCOM FORMULATIONS (INDIA) ?
Year | Profit After Tax |
---|---|
Mar2024 | ₹25 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹20 Cr |
Mar2017 | ₹11 Cr |
Mar2016 | ₹10 Cr |
How is Profit After Tax of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹25 Cr | 26.12 | |
Mar2023 | ₹20 Cr | 1.42 | |
Mar2022 | ₹20 Cr | 87.87 | |
Mar2017 | ₹11 Cr | 1.72 | |
Mar2016 | ₹10 Cr | - |
Compare Profit After Tax of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,577.3 Cr | -3.4% | -8.2% | -22.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,408.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -3.4% |
-8.2% |
-22.2% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses